Dusigitumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Dusigitumab ?
Monoclonal antibody
Source Human
Target ILGF2
Clinical data
Legal status
?
Identifiers
CAS number 1204390-13-5
ATC code None
Chemical data
Formula C6372H9824N1700O2016S54 
Mol. mass 151 kDa

Dusigitumab is a human monoclonal antibody designed for the treatment of cancer. It binds to IGLF2.[1]

This drug was developed by MedImmune, LLC.

References[edit]

  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Dusigitumab, American Medical Association.